Ro's in-home healthcare stack
Ro
Ro is turning telehealth from a simple online prescription funnel into a home based care workflow that can handle conditions requiring repeated testing, monitoring, and medication changes. The acquisitions matter because they let Ro own the practical steps between a diagnosis and a refill, from sending a test kit, to drawing blood at home, to running labs, to changing treatment, to getting medication to the patient without handing off to outside providers.
-
This is most visible in weight loss. GLP-1 care needs lab work, dose titration, side effect monitoring, and ongoing coaching, so Ro used Workpath, Kit, Modern Fertility, its own lab, and six owned pharmacies to keep that whole loop inside one system.
-
The same play also broadens Ro beyond its original male health base. Modern Fertility pulled Ro into women’s health, similar to how other telehealth companies used M&A to move into adjacent categories, like Thirty Madison buying Nurx and Maven building a larger fertility and family health platform.
-
Compared with lighter telehealth models built around one off consults and generic drugs, this home infrastructure supports categories with better retention. Hone shows why, its testosterone business depends on recurring blood work and dosage changes, which creates higher lifetime value than erectile dysfunction products with heavy generic competition.
The next phase is that home based infrastructure becomes the product, not just the support system. As telehealth pricing gets compressed, the winners will be the companies that can manage more of the care journey from the couch, especially in obesity, hormones, fertility, and other conditions where frequent monitoring makes convenience and control worth paying for.